BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7630322)

  • 1. Group A streptococci: evaluation of in vitro resistance to two macrolides.
    Millesimo M; Savoia D
    Microbios; 1995; 82(332):141-7. PubMed ID: 7630322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
    Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
    Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
    Yazgi H; Ertek M; Aktaş AE
    Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea.
    Kim S; Lee NY
    J Antimicrob Chemother; 2004 Aug; 54(2):447-50. PubMed ID: 15269193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].
    García de Lomas J; Gimeno C; Díez J; Bermejo M; Navarro D; García-Ponte L
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):24-8. PubMed ID: 10069109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
    Kaya EG; Yücel M; Karakoç AE
    Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
    Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
    Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic sensitivity of Streptococcus pyogenes in pediatrics].
    Gené A; González-Cuevas A; Juncosa T; Luaces C; Latorre C
    Enferm Infecc Microbiol Clin; 1998; 16(6):272-4. PubMed ID: 9763744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
    Seppälä H; Klaukka T; Vuopio-Varkila J; Muotiala A; Helenius H; Lager K; Huovinen P
    N Engl J Med; 1997 Aug; 337(7):441-6. PubMed ID: 9250845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalization-associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis.
    Musumeci R; Bue CL; Milazzo I; Nicoletti G; Serra A; Speciale A; Blandino G
    Clin Infect Dis; 2003 Jul; 37(2):173-9. PubMed ID: 12856208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
    Capoor MR; Nair D; Deb M; Batra K; Aggarwal P
    Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.